This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Print Page | Sign In | Join
Lymphedema Treatment Act
Share |

WOCN Participates in Lymphedema Treatment Act Hill Day

A WOCN Society representative attended the annual Capitol Hill Day on March 2nd in support of the Lymphedema Treatment Act (S.518), introduced by Maria Cantwell (D-WA) and Todd Young (R-IN) in the Senate, and in the House (H.R. 1948), introduced by Rep. Jan Schakowsky (D-IL). The Senate bill currently has 70 cosponsors and the House bill has 382 cosponsors.  

The House of Representatives passed H.R. 3, The Elijah E. Cummings Lower Drug Costs Now Act, in late 2019 which would allow the federal government to negotiate prescription drug prices with manufacturers.  This new drug pricing system would provide the federal government with significant cost savings. H.R. 3 proposes to use the savings to increase a number of Medicare benefits including adding vision, dental, and hearing benefits to Part B.  

In addition, H.R. 3 would add Medicare coverage for compression therapy of lymphedema. The language included in H.R. 3 is based on the WOCN-supported Lymphedema Treatment Act and is a huge win for beneficiaries.  House passage of this legislation is an important step, but is only part of the solution as the Senate still needs to act on these provisions before they can be sent to the President. As this point, the Senate has no plans to take up H.R. 3 as they are pursing separate legislation to address prescription drug pricing. However, by passing one chamber of Congress we are hopeful that the Lymphedema Treatment Act will be moved separately in the Senate and then sent to the President.  


Take Action


Join Now Contact Us: info@wocn.org 888-224-WOCN(9626) Advertising

Copyright 2018 Wound, Ostomy and Continence Nurses Society™. All rights reserved.

The WOCN® Society is professionally managed by Association Headquarters, a charter accredited association management company.

The Wound, Ostomy and Continence Nurses Society is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

The Wound, Ostomy and Continence Nurses Society is approved by the California Board of Registered Nursing, Provider Number CEP 15115.

The WOCN® Society does not endorse or support products or services.

PLEASE BE ADVISED: The names and contact information for all individuals listed on this site is privileged, confidential information and intended for specific purposes. No one (individual or company) may use any contact information on the WOCN Society website to contact, to distribute information to, or solicit anyone for any reason other than the intended purpose for which the name and contact information is available. Click here to view our detailed Privacy Policy.